Stock A174900 ABCLON INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases AbClon Inc.

Equities

A174900

KR7174900001

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-06-09 pm EDT 		5-day change 1st Jan Change
16,800 KRW +1.02% Intraday chart for AbClon Inc. -1.41% +13.36%
2023 AbClon Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
2023 AbClon Presents Non-Clon and Phase 1 Interim Results of its AT101 Novel CAR-T Therapy at the Annual 2023 AACR Conference CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Alligator Bioscience’s Announces Henlius Biotech has Received FDA IND Clearance for Phase 3 Initiation to Evaluate HLX22 (AC101) in 1st Line HER2+ Advanced Gastric Cancer
AQ
Alligator Bioscience Announces IND Approval for Second Phase 2 Clinical Trial of AC101 (HLX22) in Gastric Cancer developed by Shanghai Henlius Biotech in China
AQ
Alligator Bioscience : Announces First Patient Dosed in Phase II Clinical Trial with Shanghai Henlius Biotech, Inc. & AbClon, Inc.
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A174900 Stock
  4. News AbClon Inc.
  5. Press Releases